Polyclinique Clemenceau SRL
Polyclinique Clemenceau reported total assets of €1.08m at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jun 2026).
The score of Polyclinique Clemenceau shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +109 % Total assets +9 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Polyclinique Clemenceau's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 24 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 10 Aug 2023
- Year ended 31 Dec 2021filed on 30 Sep 2022
Polyclinique Clemenceau's financial analysis
- Solvency94.3%sector median: 67.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Polyclinique Clemenceau
Polyclinique Clemenceau's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0454.971.471
- VAT number
- BE0454971471
- Peppol
- Registered · 0208:0454971471 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Apr 1995
- Registered office
- 1070 Anderlecht
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
Polyclinique Clemenceau (SRL) has been based in Anderlecht since 1995, active in: medical specialists activities. For 2025, it reports a net profit of 219,863 € and equity of €1.02m; its revenue is not published. Its solvency stands at 94.3%, above the median of its sector (67.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Polyclinique Clemenceau
Companies in the same business, of comparable size and area, outside its group.
- Docteurs Truong & Saelens Medical specialists activities Gerpinnes · balance sheet €1.08m
- Dr. Katia van Landuyt - Radiologie Medical specialists activities Schelle · balance sheet €1.09m
- Dr. Thalia Bekelaar, cardioloog Medical specialists activities Nijlen · balance sheet €1.07m
- C.G.W. Medical specialists activities Rixensart · balance sheet €1.08m
- Endocrine Unit Medical specialists activities Auderghem · balance sheet €1.08m
- DOCTEUR Samuel DEHEZ Medical specialists activities Namur · balance sheet €1.08m
- Dr. Firas CHA'BAN Medical specialists activities Mortsel · balance sheet €1.08m
- Cabinet Medical Paulus Pascal Medical specialists activities Eupen · balance sheet €1.08m
Frequently asked questions about Polyclinique Clemenceau
What is the revenue of Polyclinique Clemenceau?
Polyclinique Clemenceau files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Polyclinique Clemenceau?
In Belgium, the VAT number is the company number prefixed with BE: BE0454971471 for Polyclinique Clemenceau, if the company is VAT-registered. Its company number (CBE) is 0454.971.471.
Where is the registered office of Polyclinique Clemenceau?
According to the CBE register, the registered office of Polyclinique Clemenceau is in 1070 Anderlecht.
What is the equity of Polyclinique Clemenceau?
At the close of the 2025 financial year, the equity of Polyclinique Clemenceau amounts to 1,019,894 €, a solvency of 94.3% of total assets.
Who manages Polyclinique Clemenceau?
The register lists 2 active mandates at Polyclinique Clemenceau. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Polyclinique Clemenceau
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →